IndraLab

Statements

OTUD6A inhibits hypersensitivity. 1 / 1

| 1

reach

"Knockdown of OTUD6A caused hypersensitivity to gemcitabine and methotrexate in different cancer cell lines detected (Fig. 6a, b and Supplementary Fig. 10a-d)."

38685067

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

OTUD6A inhibits hypersensitivity. 1 / 1

INDRA sources:

Databases

Reading